[A clinicopathological study of adenosquamous carcinoma of the lung]

Kyobu Geka. 1996 Nov;49(12):975-9; discussion 979-81.
[Article in Japanese]

Abstract

We studied, clinicopathologically, 34 cases of adenosquamous carcinoma (ASC) treated in our institution over the last 30 years. Its incidence was 2.3% of all primary lung cancers. Following findings were characteristics to this type of lung cancer, male dominant, old age, heavy smoker, comparatively large diameter, peripheral location, and normal level of tumor makers. The 5-year survival rates were 35.0% for ASC, 38.1% for squamous cell carcinoma (SCC), and 50.2% for adenocarcinoma (AC). The component of SCC was predominant or equal to that of AC in 27 (79.4%) ASC cases. The degree of cell differentiation was moderate and both SCC and AC components showed the same degree of cell differentiation in most cases. Lymph node metastasis was seen in 15 (48.4%) cases.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoembryonic Antigen / blood
  • Carcinoma, Adenosquamous / immunology
  • Carcinoma, Adenosquamous / mortality
  • Carcinoma, Adenosquamous / pathology*
  • Female
  • Humans
  • Lung Neoplasms / immunology
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prognosis
  • Survival Rate

Substances

  • Carcinoembryonic Antigen